Phase II Trial of Recombinant Human Interleukin-4 in Patients with Disseminated Malignant Melanoma
- 1 November 1998
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Immunotherapy
- Vol. 21 (6), 440-446
- https://doi.org/10.1097/00002371-199811000-00006